Joon Lee Analyst PerformanceManaging Director, Biotech Analyst at Truist FinancialJoon Lee is a stock analyst at Truist Financial in the healthcare sector, covering 28 publicly traded companies. Over the past year, Joon Lee has issued 38 stock ratings, including strong buy, buy, and hold recommendations. While full access to Joon Lee's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Joon Lee's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings73 Last 6 YearsBuy Recommendations89.71% 61 Buy RatingsCompanies Covered28 Unique Companies Ratings Distribution68RatingsDistribution of strong buy, buy, hold, and sell ratings by Joon Lee.RatingPercentageCount Strong Buy10.3%7 ratings Buy79.4%54 ratings Hold10.3%7 ratings Sell0.0%0 ratingsOut of 68 total stock ratings issued by Joon Lee at Truist Financial, the majority (79.4%) have been Buy recommendations, followed by 10.3% Strong Buy and 10.3% Hold.Best & Worst CallsBest Call0000.0%PRAXMar 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%EDITAug 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ28 companiesJoon Lee, an analyst at Truist Financial, currently covers 28 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare28 companies100.0%Joon Lee of Truist Financial specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY22 companies78.6%PHARMACEUTICALS6 companies21.4% Joon Lee's Ratings History at Truist Financial Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsRAPPRapport Therapeutics11/5/2026Lower Price Target$23.72$64.00Buy$0.0000.00% ROIBBIOBridgeBio Pharma10/30/2026Reiterated Rating$73.42Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals10/30/2026Lower Price Target$169.48$329.00Buy$0.0000.00% ROIRAPPRapport Therapeutics10/15/2026Initiated Coverage$28.33$71.00Buy$0.0000.00% ROIWVEWAVE Life Sciences10/15/2026Initiated Coverage$3.09$11.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals10/15/2026Initiated Coverage$42.70$88.00Buy$0.0000.00% ROICRSPCRISPR Therapeutics10/15/2026Initiated Coverage$50.22$52.00Neutral$0.0000.00% ROIQUREuniQure10/15/2026Initiated Coverage$20.97$48.00Buy$0.0000.00% ROIPTCTPTC Therapeutics10/15/2026Initiated Coverage$59.67$90.00Buy$0.0000.00% ROIBBIOBridgeBio Pharma10/15/2026Initiated Coverage$64.94$92.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. ASNDAscendis Pharma A/S10/15/2026Initiated Coverage$227.00$269.00Buy$0.0000.00% ROIRAREUltragenyx Pharmaceutical10/15/2026Initiated Coverage$14.90$16.00Neutral$0.0000.00% ROIALNYAlnylam Pharmaceuticals10/15/2026Initiated Coverage$233.06$354.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical10/15/2026Initiated Coverage$56.69$88.00Buy$0.0000.00% ROISLDBSolid Biosciences10/14/2026Initiated Coverage$5.47$20.00Buy$0.0000.00% ROIVKTXViking Therapeutics10/14/2026Initiated Coverage$25.47$94.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals10/14/2026Upgrade$231.83Strong-Buy$0.0000.00% ROIBBIOBridgeBio Pharma10/14/2026Upgrade$66.39Strong-Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical10/14/2026Upgrade$54.68Strong-Buy$0.0000.00% ROIRAPPRapport Therapeutics10/14/2026Upgrade$27.57Strong-Buy$0.0000.00% ROIRAREUltragenyx Pharmaceutical10/14/2026Upgrade$14.54Hold$0.0000.00% ROISLDBSolid Biosciences10/14/2026Upgrade$5.53Strong-Buy$0.0000.00% ROIVKTXViking Therapeutics10/14/2026Upgrade$25.17Strong-Buy$0.0000.00% ROIWVEWAVE Life Sciences10/14/2026Upgrade$3.13Strong-Buy$0.0000.00% ROIVKTXViking Therapeutics9/23/2026Boost Price Target$39.41$87.00Buy$0.0000.00% ROIVRTXVertex Pharmaceuticals3/11/2026Boost Price Target$490.02$525.00Buy$0.0000.00% ROIANABAnaptysBio3/6/2026Boost Price Target$56.27$50.00Hold$0.0000.00% ROIAXSMAxsome Therapeutics2/23/2026Set Price Target$174.72$200.00$0.0000.00% ROIPRAXPraxis Precision Medicines2/20/2026Boost Price Target$333.71$700.00Buy$0.0000.00% ROIJAZZJazz Pharmaceuticals1/12/2026Boost Price Target$161.36$230.00Buy$0.0000.00% ROIARGXargenex1/8/2026Boost Price Target$806.40$1,030.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical12/23/2025Boost Price Target$59.28$100.00Buy$0.0000.00% ROIWVEWAVE Life Sciences12/15/2025Boost Price Target$16.56$50.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines12/8/2025Boost Price Target$266.63$500.00Buy$0.0000.00% ROIALKSAlkermes11/17/2025Boost Price Target$29.04$55.00Buy$0.0000.00% ROIALKSAlkermes11/11/2025Initiated Coverage$32.65$50.00Buy$0.0000.00% ROINTLAIntellia Therapeutics11/10/2025Reiterated Rating$9.92$14.00Buy$00.0000.00% ROIANABAnaptysBio11/10/2025Boost Price Target$34.43$36.00Hold$00.0000.00% ROIRAREUltragenyx Pharmaceutical11/5/2025Lower Price Target$32.00$90.00Buy$00.0000.00% ROIBMRNBioMarin Pharmaceutical10/28/2025Lower Price Target$55.03$80.00Buy$00.0000.00% ROIEvery Starlink dish pays this stock (Ad)There's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now he's filed to launch 1,000,000 AI satellites, a move Dylan believes could mean a 100X bigger royalty bill starting December 8th. This free pick names the public company collecting on every unit.Claim your free stock pick before December 8thADVMAdverum Biotechnologies10/24/2025Set Price Target$4.07$5.00$0.0000.00% ROIADVMAdverum Biotechnologies10/24/2025Downgrade$4.24Hold$0.0000.00% ROIPRAXPraxis Precision Medicines10/17/2025Reiterated Rating$186.69$360.00Buy$000.0000.00% ROIRAPPRapport Therapeutics9/16/2025Initiated Coverage$24.73$44.00Buy$00.0000.00% ROIARGXargenex9/15/2025Boost Price Target$756.38$918.00Buy$000.0000.00% ROIVRTXVertex Pharmaceuticals8/5/2025Lower Price Target$392.94$490.00Buy$000.0000.00% ROIPTCTPTC Therapeutics7/29/2025Boost Price Target$49.79$86.00Buy$00.0000.00% ROIPTCTPTC Therapeutics6/17/2025Initiated Coverage$51.87$80.00Buy$00.0000.00% ROICORTCorcept Therapeutics5/6/2025Set Price Target$70.46$135.00$00.0000.00% ROIVKTXViking Therapeutics4/28/2025Reiterated Rating$25.54$75.00Buy$00.0000.00% ROIARVNArvinas4/9/2025Lower Price Target$6.19$21.00Buy$00.0000.00% ROICORTCorcept Therapeutics3/31/2025Boost Price Target$102.71$150.00Buy$00.0000.00% ROINTLAIntellia Therapeutics3/4/2025Lower Price Target$8.98$50.00Buy$00.0000.00% ROIPRAXPraxis Precision Medicines3/3/2025Lower Price Target$37.71$85.00Buy$000.0000.00% ROIAXSMAxsome Therapeutics2/19/2025Boost Price Target$125.57$200.00Buy$000.0000.00% ROICRSPCRISPR Therapeutics2/12/2025Boost Price Target$42.39$120.00Buy$00.0000.00% ROIVRTXVertex Pharmaceuticals2/11/2025Boost Price Target$460.13$520.00Buy$000.0000.00% ROIAXSMAxsome Therapeutics2/3/2025Boost Price Target$106.86$190.00Buy$000.0000.00% ROILRMRLarimar Therapeutics1/29/2025Initiated Coverage$3.48$18.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines1/21/2025Boost Price Target$74.33$175.00Buy$000.0000.00% ROIARGXargenex1/14/2025Reiterated Rating$673.54$700.00Buy$000.0000.00% ROIAXSMAxsome Therapeutics1/13/2025Boost Price Target$80.05$180.00Buy$000.0000.00% ROISLDBSolid Biosciences1/8/2025Initiated Coverage$3.92$16.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital MarketsRaymond James Financial Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
